Cargando…
A Global Intellectual Property Waiver is Still Needed to Address the Inequities of COVID-19 and Future Pandemic Preparedness
In October 2020, India and South Africa submitted a proposal to the World Trade Organization (WTO) to suspend IP on all COVID-19 vaccines, therapeutics, and diagnostics until widespread vaccination could help achieve immunity among people in low- and middle-income countries. After 18 months, the fin...
Autores principales: | Amin, Tahir, Kesselheim, Aaron S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500257/ https://www.ncbi.nlm.nih.gov/pubmed/36124939 http://dx.doi.org/10.1177/00469580221124821 |
Ejemplares similares
-
Mixed response to COVID-19 intellectual property waiver
por: Zarocostas, John
Publicado: (2022) -
Assessment of the proposed intellectual property waiver as a mechanism to address the COVID-19 vaccine scarcity problem
por: Barnes-Weise, Julia, et al.
Publicado: (2022) -
Time to boost COVID-19 vaccine manufacturing: The need for intellectual property waiver by big pharma
por: Okereke, M., et al.
Publicado: (2021) -
What next for a COVID-19 intellectual property waiver?
por: Zarocostas, John
Publicado: (2021) -
US Support for a WTO Waiver of COVID-19 Intellectual Property
por: Contreras, Jorge L.
Publicado: (2021)